Generics maker Laurus Lab’s net profit more than doubles in Q1 on strong CDMO business growth
24 July 20261 min read0 views
Within CDMO, small molecules segment increased 69%, driven by growth in late-stage clinical and commercial API supplies.
Related Articles
Business11
'To youngsters': PM Modi posts 2nd selfie video
'To youngsters': PM Modi posts 2nd selfie video
Economictimes.indiatimes.com
4 hours ago4Business11
Delhi Metro closures, July 25: 18 stations closed
Delhi Metro closures, July 25: 18 stations closed
Economictimes.indiatimes.com
4 hours ago4
Business11
2,500 with criminal records found at Jantar Mantar
2,500 with criminal records found at Jantar Mantar
Economictimes.indiatimes.com
4 hours ago4
0Business00
Refinery expansion plans will not be affected by temporary flare-up, confident of recouping losses: Bharat Petroleum
Senior executives at BPCL expect oil prices to cool off after the latest flare-up which is expected to be temporary.
The Hindu
5 hours ago5